Ellodi Pharmaceuticals Is A Gastroenterology Focused Specialty Pharmaceutical Company Aiming To Advance Treatments For Eosinophilic Esophagitiseoe A Rare And Chronic Allergic Inflammatory Conditionthe Company Was Established In 2020 To Accelerate Clinical Development Of Eoe Therapies And Build On The Work Initiated By Adare Pharmaceuticalsparticularly Apt 1011Which Is Currently In A Phase 3 Clinical Trialdespite Growing Awareness Of Eoe And Its Underserved Patient Populationno First Line Fda Approved Treatment Exists For The Disease Today Ellodi Pharmaceuticals Has Assembled A Seasoned Team With Deep Expertise In Developing And Commercializing Innovative Therapies For Gastrointestinal Disorders And Rare Diseaseswith Patients And Caregivers At The Center Of Every Decision We Makewe Are Focused On Developing And Delivering Innovative Therapies That Can Meaningfully Improve And Transform The Lives Of Patients With Eoe
